Steve Harr - Mar 6, 2025 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
President & CEO, Director
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Steve Harr
Stock symbol
SANA
Transactions as of
Mar 6, 2025
Transactions value $
-$32,819
Form type
4
Date filed
3/10/2025, 08:12 PM
Previous filing
Mar 8, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Options Exercise $0 +50K +0.64% $0.00 7.89M Mar 7, 2025 Direct
transaction SANA Common Stock Tax liability -$32.8K -12.8K -0.16% $2.56 7.88M Mar 10, 2025 Direct
holding SANA Common Stock 683K Mar 6, 2025 Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015
holding SANA Common Stock 167K Mar 6, 2025 Held by Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021 F1
holding SANA Common Stock 167K Mar 6, 2025 Held by Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021 F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Restricted Stock Units Award $0 +167K $0.00 167K Mar 6, 2025 Common Stock 167K Direct F2, F3
transaction SANA Stock Option (Right to Buy) Award $0 +750K $0.00 750K Mar 6, 2025 Common Stock 750K $2.55 Direct F4
transaction SANA Restricted Stock Units Options Exercise $0 -50K -25% $0.00 150K Mar 7, 2025 Common Stock 50K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Brian L. Harr is the trustee of these trusts, whose sole beneficiaries are members of the reporting person's immediate family.
F2 Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
F3 The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F4 The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F5 The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.